BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 33560322)

  • 1. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    Ducrocq G; Gonzalez-Juanatey JR; Puymirat E; Lemesle G; Cachanado M; Durand-Zaleski I; Arnaiz JA; Martínez-Sellés M; Silvain J; Ariza-Solé A; Ferrari E; Calvo G; Danchin N; Avendaño-Solá C; Frenkiel J; Rousseau A; Vicaut E; Simon T; Steg PG;
    JAMA; 2021 Feb; 325(6):552-560. PubMed ID: 33560322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial.
    Ducrocq G; Calvo G; González-Juanatey JR; Durand-Zaleski I; Avendano-Sola C; Puymirat E; Lemesle G; Arnaiz JA; Martínez-Sellés M; Rousseau A; Cachanado M; Vicaut E; Silvain J; Karam C; Danchin N; Simon T; Steg PG;
    Clin Cardiol; 2021 Feb; 44(2):143-150. PubMed ID: 33405291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
    Carson JL; Brooks MM; Hébert PC; Goodman SG; Bertolet M; Glynn SA; Chaitman BR; Simon T; Lopes RD; Goldsweig AM; DeFilippis AP; Abbott JD; Potter BJ; Carrier FM; Rao SV; Cooper HA; Ghafghazi S; Fergusson DA; Kostis WJ; Noveck H; Kim S; Tessalee M; Ducrocq G; de Barros E Silva PGM; Triulzi DJ; Alsweiler C; Menegus MA; Neary JD; Uhl L; Strom JB; Fordyce CB; Ferrari E; Silvain J; Wood FO; Daneault B; Polonsky TS; Senaratne M; Puymirat E; Bouleti C; Lattuca B; White HD; Kelsey SF; Steg PG; Alexander JH;
    N Engl J Med; 2023 Dec; 389(26):2446-2456. PubMed ID: 37952133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2).
    Reeves BC; Pike K; Rogers CA; Brierley RC; Stokes EA; Wordsworth S; Nash RL; Miles A; Mumford AD; Cohen A; Angelini GD; Murphy GJ
    Health Technol Assess; 2016 Aug; 20(60):1-260. PubMed ID: 27527344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.
    Hajjar LA; Vincent JL; Galas FR; Nakamura RE; Silva CM; Santos MH; Fukushima J; Kalil Filho R; Sierra DB; Lopes NH; Mauad T; Roquim AC; Sundin MR; Leão WC; Almeida JP; Pomerantzeff PM; Dallan LO; Jatene FB; Stolf NA; Auler JO
    JAMA; 2010 Oct; 304(14):1559-67. PubMed ID: 20940381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    Mazer CD; Whitlock RP; Fergusson DA; Hall J; Belley-Cote E; Connolly K; Khanykin B; Gregory AJ; de Médicis É; McGuinness S; Royse A; Carrier FM; Young PJ; Villar JC; Grocott HP; Seeberger MD; Fremes S; Lellouche F; Syed S; Byrne K; Bagshaw SM; Hwang NC; Mehta C; Painter TW; Royse C; Verma S; Hare GMT; Cohen A; Thorpe KE; Jüni P; Shehata N;
    N Engl J Med; 2017 Nov; 377(22):2133-2144. PubMed ID: 29130845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    Mazer CD; Whitlock RP; Fergusson DA; Belley-Cote E; Connolly K; Khanykin B; Gregory AJ; de Médicis É; Carrier FM; McGuinness S; Young PJ; Byrne K; Villar JC; Royse A; Grocott HP; Seeberger MD; Mehta C; Lellouche F; Hare GMT; Painter TW; Fremes S; Syed S; Bagshaw SM; Hwang NC; Royse C; Hall J; Dai D; Mistry N; Thorpe K; Verma S; Jüni P; Shehata N;
    N Engl J Med; 2018 Sep; 379(13):1224-1233. PubMed ID: 30146969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses.
    Durand-Zaleski I; Ducrocq G; Mimouni M; Frenkiel J; Avendano-Solá C; Gonzalez-Juanatey JR; Ferrari E; Lemesle G; Puymirat E; Berard L; Cachanado M; Arnaiz JA; Martínez-Sellés M; Silvain J; Ariza-Solé A; Calvo G; Danchin N; Paco S; Drouet E; Abergel H; Rousseau A; Simon T; Steg PG
    Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):194-202. PubMed ID: 35612990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
    Carson JL; Brooks MM; Chaitman BR; Alexander JH; Goodman SG; Bertolet M; Abbott JD; Cooper HA; Rao SV; Triulzi DJ; Fergusson DA; Kostis WJ; Noveck H; Simon T; Steg PG; DeFilippis AP; Goldsweig AM; Lopes RD; White H; Alsweiler C; Morton E; Hébert PC;
    Am Heart J; 2023 Mar; 257():120-129. PubMed ID: 36417955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-Trial.
    Meybohm P; Lindau S; Treskatsch S; Francis R; Spies C; Velten M; Wittmann M; Gueresir E; Stoppe C; Kowark A; Coburn M; Selleng S; Baschin M; Jenichen G; Meersch M; Ermert T; Zarbock A; Kranke P; Kredel M; Helf A; Laufenberg-Feldmann R; Ferner M; Wittenmeier E; Gürtler KH; Kienbaum P; de Abreu MG; Sander M; Bauer M; Seyfried T; Gruenewald M; Choorapoikayil S; Mueller MM; Seifried E; Brosteanu O; Bogatsch H; Hasenclever D; Zacharowski K;
    Trials; 2019 Feb; 20(1):101. PubMed ID: 30717805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial.
    Carson JL; Sieber F; Cook DR; Hoover DR; Noveck H; Chaitman BR; Fleisher L; Beaupre L; Macaulay W; Rhoads GG; Paris B; Zagorin A; Sanders DW; Zakriya KJ; Magaziner J
    Lancet; 2015 Mar; 385(9974):1183-9. PubMed ID: 25499165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
    Hébert PC; Yetisir E; Martin C; Blajchman MA; Wells G; Marshall J; Tweeddale M; Pagliarello G; Schweitzer I;
    Crit Care Med; 2001 Feb; 29(2):227-34. PubMed ID: 11246298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants: The ETTNO Randomized Clinical Trial.
    Franz AR; Engel C; Bassler D; Rüdiger M; Thome UH; Maier RF; Krägeloh-Mann I; Kron M; Essers J; Bührer C; Rellensmann G; Rossi R; Bittrich HJ; Roll C; Höhn T; Ehrhardt H; Avenarius S; Körner HT; Stein A; Buxmann H; Vochem M; Poets CF;
    JAMA; 2020 Aug; 324(6):560-570. PubMed ID: 32780138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liberal or restrictive transfusion in high-risk patients after hip surgery.
    Carson JL; Terrin ML; Noveck H; Sanders DW; Chaitman BR; Rhoads GG; Nemo G; Dragert K; Beaupre L; Hildebrand K; Macaulay W; Lewis C; Cook DR; Dobbin G; Zakriya KJ; Apple FS; Horney RA; Magaziner J;
    N Engl J Med; 2011 Dec; 365(26):2453-62. PubMed ID: 22168590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Evaluation of a Restrictive Transfusion Strategy in Older Adults with Hip Fracture.
    Zerah L; Dourthe L; Cohen-Bittan J; Verny M; Raux M; Mézière A; Khiami F; Tourette C; Neri C; Le Manach Y; Riou B; Vallet H; Boddaert J
    J Am Geriatr Soc; 2018 Jul; 66(6):1151-1157. PubMed ID: 29676780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In patients with AMI and anemia, a restrictive vs. liberal blood transfusion strategy was noninferior for 30-d MACE.
    Jiang D; Garcia D
    Ann Intern Med; 2021 Jul; 174(7):JC77. PubMed ID: 34224267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restrictive vs. Liberal Red Blood Cell Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: A Systematic Review and Meta-Analysis.
    Zhang Y; Xu Z; Huang Y; Ye Q; Xie N; Zeng L; Lian X; Dai Y; Chen J; He P; Tan N; Liu Y
    Front Cardiovasc Med; 2021; 8():736163. PubMed ID: 34869640
    [No Abstract]   [Full Text] [Related]  

  • 19. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease.
    Carson JL; Brooks MM; Abbott JD; Chaitman B; Kelsey SF; Triulzi DJ; Srinivas V; Menegus MA; Marroquin OC; Rao SV; Noveck H; Passano E; Hardison RM; Smitherman T; Vagaonescu T; Wimmer NJ; Williams DO
    Am Heart J; 2013 Jun; 165(6):964-971.e1. PubMed ID: 23708168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial.
    Gonzalez-Juanatey JR; Lemesle G; Puymirat E; Ducrocq G; Cachanado M; Arnaiz JA; Martínez-Sellés M; Silvain J; Ariza-Solé A; Ferrari E; Calvo G; Danchin N; Avendano-Solá C; Rousseau A; Vicaut E; Gonzalez-Ferrero T; Steg PG; Simon T;
    Circulation; 2022 Feb; 145(6):486-488. PubMed ID: 35130052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.